Business Description
NuVasive Inc
NAICS : 339112
SIC : 3841
Description
NuVasive Inc is a medical technology company focused on developing, manufacturing, selling and providing procedural solutions for spine surgery, with a guiding purpose to transform surgery, advance care and change lives. The company has a portfolio of procedurally integrated spine surgery solutions, including surgical access instruments, spinal implants, fixation systems, biologics, and enabling technologies, as well as systems and services for intraoperative neuromonitoring. It also develop and sell magnetically adjustable implant systems for spine and specialized orthopedic procedures.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.25 | |||||
| Equity-to-Asset | 0.39 | |||||
| Debt-to-Equity | 1.16 | |||||
| Debt-to-EBITDA | 4.64 | |||||
| Interest Coverage | 4.79 | |||||
| Piotroski F-Score | 7/9 | |||||
| Altman Z-Score | 1.66 | |||||
| Beneish M-Score | -2.59 | |||||
| WACC vs ROIC | ||||||
Growth Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -1.6 | |||||
| 3-Year EBITDA Growth Rate | -7.6 | |||||
| 3-Year EPS without NRI Growth Rate | -14.8 | |||||
| 3-Year FCF Growth Rate | -36 | |||||
| 3-Year Book Growth Rate | -1.7 | |||||
| Future 3-5Y EPS without NRI Growth Rate | 14.45 | |||||
| Future 3-5Y Total Revenue Growth Rate | 6.16 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 52.51 | |||||
| 9-Day RSI | 39.43 | |||||
| 14-Day RSI | 36.94 | |||||
| 6-1 Month Momentum % | 0.76 | |||||
| 12-1 Month Momentum % | -16.11 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.21 | |||||
| Quick Ratio | 0.74 | |||||
| Cash Ratio | 0.35 | |||||
| Days Inventory | 358.28 | |||||
| Days Sales Outstanding | 70.72 | |||||
| Days Payable | 85.75 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 72 | |||||
| Operating Margin % | 6.94 | |||||
| Net Margin % | 3.36 | |||||
| ROE % | 4.89 | |||||
| ROA % | 1.86 | |||||
| ROIC % | 3.54 | |||||
| ROC (Joel Greenblatt) % | 8.92 | |||||
| ROCE % | 4.19 | |||||
| Years of Profitability over Past 10-Year | 7 |
GF Value Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 53.56 | |||||
| Forward PE Ratio | 17.24 | |||||
| PE Ratio without NRI | 53.56 | |||||
| Shiller PE Ratio | 90.54 | |||||
| Price-to-Owner-Earnings | 845.11 | |||||
| PS Ratio | 1.85 | |||||
| PB Ratio | 2.28 | |||||
| Price-to-Tangible-Book | 44.12 | |||||
| Price-to-Free-Cash-Flow | 65.57 | |||||
| Price-to-Operating-Cash-Flow | 12.76 | |||||
| EV-to-EBIT | 39.32 | |||||
| EV-to-Forward-EBIT | 15.62 | |||||
| EV-to-EBITDA | 12.65 | |||||
| EV-to-Forward-EBITDA | 10.36 | |||||
| EV-to-Revenue | 2.28 | |||||
| EV-to-Forward-Revenue | 2.15 | |||||
| EV-to-FCF | 92.36 | |||||
| Price-to-Projected-FCF | 1.87 | |||||
| Price-to-Median-PS-Value | 0.67 | |||||
| Price-to-Graham-Number | 9.9 | |||||
| Earnings Yield (Greenblatt) % | 2.54 | |||||
| Forward Rate of Return (Yacktman) % | -4.03 |
How NuVasive Inc (NUVA) Makes Its Money
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:NUVA
Peter Lynch Chart
Performance
Dividend
Log
Annualized Return %
Total Annual Return %
NuVasive Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 1,201.942 | ||
| EPS (TTM) ($) | 0.71 | ||
| Beta | 0.86 | ||
| Volatility % | 35.71 | ||
| 14-Day RSI | 36.94 | ||
| 14-Day ATR ($) | 1.20621 | ||
| 20-Day SMA ($) | 39.9075 | ||
| 12-1 Month Momentum % | -16.11 | ||
| 52-Week Range ($) | 35.17 - 60.47 | ||
| Shares Outstanding (Mil) | 52.19 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
NuVasive Inc Filings
| Document | Form | Filing Date | ||
|---|---|---|---|---|
| No Filing Data | ||||
NuVasive Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
NuVasive Inc Frequently Asked Questions
What is NuVasive Inc(NUVA)'s stock price today?
The current price of NUVA is $38.03. The 52 week high of NUVA is $60.47 and 52 week low is $35.17.
When is next earnings date of NuVasive Inc(NUVA)?
The next earnings date of NuVasive Inc(NUVA) is 2023-05-04 Est..
Does NuVasive Inc(NUVA) pay dividends? If so, how much?
NuVasive Inc(NUVA) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
